This webinar will provide the evidence for PET imaging in medullary thyroid cancer according to the literature and the to international recommendations with a focus on the available radiopharmaceuticals and perspectives. Learning Objectives: The aim of this webinar is to understand and to learn the correct use of PET radiopharmaceuticals for staging and restaging medullary […]
This webinar will provide knowledge about hybrid imaging SPECT/ CT and PET/CT: CT acquisition protocol, added value of CACS and incidental findings on CTAC. Learning Objectives: The aim of the webinar is to: Faculty Registration Event Overview
Early phase SPECT has the potential to expand the diagnosis spectrum of disphosphonate scintigraphy in non-oncologic situations. Incorporated in a clinical routine, it has the ability to focus the nuclear medicine physician attention on the most inflammatory lesions whichever they might be osseous, para-osseous ou extra-osseous. Our 1.5 day course is intended to be a […]
Patients workflows and acquisition protocols in PET/CT and PET/MR with different radiotracers for cardiovascular nuclear medicine imaging. Learning Objectives: To learn how to manage radioactive generators 82Sr/82Rb and to acquire cardiovascular imaging in PET/CT or PET/MR and other acquisition protocols. Faculty Registration Event Overview
A large oncological framework will be the topic of the first session: three lectures by a high quoted Paediatric Oncologist: epidemiology, aetiological factors, and general classification of Paediatric Hodgkin and non-Hodgkin Lymphomas and main therapeutic strategies and prognostic considerations. The two valuable nuclear medicine experts will discuss the role of molecular imaging in paediatric lymphomas: […]
General overview of the EANM/SNMMI guidelines on FDG PET/CT in inflammation and infection. Learning Objectives: The aim of this course is to summarize the major indications for FDG PET/CT in infection and inflammation, based on the updated guidelines for nuclear medicine practice provided by the EANM/SNMMI. Faculty Registration Event Overview
Breast cancer is the most common cancer in women worldwide and it is still one of the leading causes of morbi-mortality, therefore being a major concern. 2-FDG PET/CT is commonly used in the clinical management of patients with breast cancer, with significant impact on clinical management. Currently, there is robust evidence supporting the usefulness of […]
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
